Researchers have found a new way to reactivate fetal hemoglobin without the need for gene-editing therapy, according to a new study.

Disc Medicine will be enrolling 24 adults with SCD in its newly launched trial testing DISC-3405 at three doses for easing ...

Columnist Oluwatosin Adesoye encourages medical professional to be more mindful about the care they provide to sickle cell ...

Although she understands her illness, columnist Michelle Harlan is still learning how to communicate and disclose her sickle ...

Disc Medicine says it’s planning to launch a clinical trial before the end of the year that will test DISC-3405, its treatment candidate for reducing high iron levels and easing iron overload, in ...

The European Medicines Agency (EMA) has confirmed the continuing suspension of marketing authorization for Pfizer’s sickle cell disease (SCD) treatment Oxbryta ...

Communication is necessary for any relationship to form, whether it’s platonic or romantic. The more I experience different types of relationships, the more I realize how pivotal communication is in ...

Treatment with hydroxyurea increases blood oxygen levels during sleep in children with sickle cell disease (SCD), but it does not meaningfully lessen sleep disturbances, a study reports. Compared with ...

I learned almost by accident that last week was Invisible Disabilities Week. I had no idea such a week even existed, which says something about the invisibility of disabilities in our society. The ...

A blood test measuring a protein called placental growth factor (PlGF) may help identify women with sickle cell disease (SCD) who are at risk of developing early-onset preeclampsia, a new study shows.